Seqirus Scientist Liverpool

OUR COMPANY

We are CSL Seqirus

Securing Health for All of Us

Derived from the expression 'securing health for all of us', CSL Seqirus has public health protection at its core. This reflects the promise of our parent company CSL, founded in 1916 to save lives and protect the health of people. Our first true test came with the Spanish Influenza Pandemic and we have been committed to the fight against influenza ever since. 

Influenza kills. But at CSL Seqirus, we believe it shouldn’t be that way. As the only vaccine company with a singular global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies and the latest methods of production and distribution. Together with our partners we’re on the front line every day, protecting communities from seasonal influenza and global pandemic threats.

Our vision is a world protected from influenza. 

100 Years

As part of the CSL Group, CSL Seqirus draws on over a century of experience in influenza vaccines. From 1916 to today, CSL has been driven by the promise to save lives using the latest technologies.

Dr Penfold

1916

Commonwealth Serum Laboratories (CSL) is established to service the health needs of an infant Australian nation.

1916

1919 Flu ampoule

1919

When the deadly Spanish influenza pandemic strikes Australia, CSL responds rapidly with 3 million doses of a mixed bacterial vaccine.

1919

Early antivenom ampoule

1930

CSL releases a tiger snake antivenom, and goes on to develop antivenoms for Australia’s most venomous creatures.

1930

CSL's production during WWII

1944

Production commences on an influenza virus vaccine and the first 1 million doses are supplied to Australian and British troops.

1944

Lady with eggs

1951

WHO designates CSL as a Influenza Reference Laboratory to enhance Southern Hemisphere influenza surveillance.

1951

Flu vaccine production 1950s

1957-8

CSL responds quickly to the Asian influenza pandemic, producing 1.6 million doses of vaccine.

1957

Flu production or Hong King flu vaccine poster

1968-9

As the Hong Kong influenza pandemic emerges, CSL produces 5 million doses of vaccine to protect the region.

1968

Dr Warburton

1992

WHO designates CSL as an Influenza Collaborating Centre, strengthening its role in the global influenza network.

1992

stock exchange

1994

CSL becomes a private company.

1994

Export to NH

2002

CSL extends its influenza vaccine supply into the Northern Hemisphere.

2002

Swine flu

2009

The organisation's rapid response to the H1N1 (swine flu) pandemic sees Australia become one of the first countries in the world to roll-out vaccine to its population, with stocks also donated to the WHO.

2009

Seqirus Holly Springs

2015

CSL Seqirus, one of the largest influenza vaccine manufacturers in the world, is created when CSL acquires the Novartis' influenza vaccine business, combining it with bioCSL.

2015

Launch 3 product - patient image

2016

CSL Seqirus launches three new products and is well positioned for the future.

2016

Holly Springs Manufacturing - image library

2018

CSL Seqirus secures FDA approval for next generation cell-based influenza vaccine manufacturing process.

2018

It began with a promise.

Introducing our first-ever brand anthem film – PROMISES. Our parent company CSL was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Seqirus has grown into a global influenza prevention leader.  This visual narrative symbolizes the passion, drive, and spirit of our more than 25,000 employees to develop and deliver lifesaving medicines to protect human health.

Group planting tree

Corporate Responsibility

At CSL Seqirus, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities. We believe that behaving responsibly is critical to the sustainability of our company.

Learn more
People / Patients enjoying life

In the Community

Helping people and communities by lending our expertise, supporting education and improving access to influenza vaccines and life-saving products, is part of our Corporate Responsibility.

Learn more about Sustainability at CSL
The CSL Seqirus leadership team

Our Leadership

The CSL Seqirus Leadership Team has deep expertise in the business of influenza and a shared commitment to public health.

Learn more

Our Values

Make People And Patients Your Passion

See patients as people first.

Show up wholeheartedly for everyone we serve.

Deliver on our promises today for a healthier world tomorrow.

Reach For The Unreachable

Reimagine. Reinvent. Reinspire.

Understand the needs of others and proactively meet them.

Learn from every hurdle, advance with different approaches.

Stay nimble as we relentlessly pursue what’s next.

Walk Your Talk

Live our values through ethical actions.

Strive to do right for people and the planet.

Respect others the way you want to be respected.

Assume good intentions to create an atmosphere of trust.

Adventure Together

Debate openly. Unite quickly and decisively.

Work together, have fun together, win together.

Stay humble in your work and proud in our purpose.

Activate the collective power of people; the best can come from anyone and anywhere.

Make Yourself Proud

Turn imagination into action and action into results.

Ask yourself, "How can this be better?" and follow through.

Celebrate each other for reaching beyond.

AP-CRP-23-0001